leucemia mieloide acuta p53 mutata: le nuove terapie in studio
Published 2 years ago • 899 plays • Length 5:05Download video MP4
Download video MP3
Similar videos
-
7:06
tp53 in myeloid leukemias: targeting the guardian of the genome
-
5:51
leucemia mieloide acuta flt3 mutata: terapie già disponibili e altre in studio
-
4:21
leucemia mieloide acuta: le nuove prospettive di cura con gli inibitori di idh1
-
1:03
significance of p53 mutations in aml
-
7:57
leucemia mieloide acuta: le terapie disponibili e ruolo di venetoclax
-
1:00:16
webinar video: role of tp53 gene in hematolymphoid malignancies and multiple myeloma
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
4:46
la terapia di mantenimento della leucemia mieloide acuta
-
20:18
case study 2: a patient with a myeloid neoplasm and a tp53 mutation
-
3:03
mutant p53 re-activator apr-246 in mds/aml
-
5:16
stability of rare tp53 co-mutations in aml patients
-
3:00
apr-246 in tp53 mutated mds and aml
-
1:59
depth of molecular response in patients with tp53m mds & aml treated with magrolimab and azacitidine
-
1:56
dr. pemmaraju on the challenges of targeting tp53 mutations in mds/aml
-
1:31
dr. eskelund on study of tp53 mutations in mantle cell lymphoma
-
5:45
pathogenic tp53 mutations associated with poor prognosis in pediatric aml
-
6:19
leucemia mieloide acuta flt3 , combo gilteritinib-venetoclax attiva nei casi altamente pretrattati
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients